[Anti-angiogenetic therapy of tumors in the animal experiment].
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D018827:Carcinoma, Lewis Lung / Q000098:blood supply* / Q000473:pathology; D002455:Cell Division / Q000187:drug effects; D003094:Collagen / Q000494:pharmacology*; D019008:Drug Resistance, Neoplasm; D043169:Endostatins; D005354:Fibrosarcoma / Q000098:blood supply* / Q000473:pathology; D008546:Melanoma, Experimental / Q000098:blood supply* / Q000473:pathology; D051379:Mice; D008833:Microcirculation / Q000187:drug effects; D009364:Neoplasm Recurrence, Local / Q000473:pathology; D009389:Neovascularization, Pathologic / Q000473:pathology*; D010446:Peptide Fragments / Q000494:pharmacology*
D000970:Antineoplastic Agents; D043169:Endostatins; D010446:Peptide Fragments; D003094:Collagen
Antiangiogenetische Therapie von Tumoren im Tierexperiment.